Amerise Biosciences Limited (BOM:531681)

Amerise Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	0.21	0.14	0.13	0.19	0.25
Cash & Short-Term Investments	0.16	0.21	0.14	0.13	0.19	0.25
Cash Growth	-55.46%	55.15%	4.61%	-32.69%	-23.13%	36.50%
Accounts Receivable	-	-	-	62.17	-	-
Receivables	-	-	-	62.17	-	-
Other Current Assets	-	0.02	-	-0	-	-
Total Current Assets	-	0.23	0.14	62.29	0.19	0.25
Long-Term Investments	-	22.65	45.66	46.91	30.41	53.71
Other Long-Term Assets	-	-	-	-0	-	-
Total Assets	-	53.9	56.47	119.88	56.28	60.22
Accounts Payable	-	-	-	62.66	4.8	4.8
Other Current Liabilities	-	0.16	0.37	0.01	0.57	1.15
Total Current Liabilities	-	0.16	0.37	62.67	5.38	5.95
Long-Term Debt	-	-	0.9	0.83	-	-
Other Long-Term Liabilities	-	-	-	-0	-	-
Total Liabilities	-	0.16	1.27	63.49	5.38	5.95
Common Stock	-	66.07	66.07	66.07	66.07	66.07
Retained Earnings	-	-13.14	-11.68	-10.49	-15.98	-12.61
Comprehensive Income & Other	-	0.81	0.81	0.81	0.81	0.81
Shareholders' Equity	52.92	53.74	55.2	56.39	50.9	54.27
Total Liabilities & Equity	-	53.9	56.47	119.88	56.28	60.22
Total Debt	-	-	0.9	0.83	-	-
Net Cash (Debt)	0.16	0.21	-0.76	-0.7	0.19	0.25
Net Cash Growth	-	-	-	-	-23.13%	36.50%
Net Cash Per Share	-	0.00	-0.01	-0.01	0.00	0.00
Filing Date Shares Outstanding	-	66.07	66.07	66.07	66.07	66.07
Total Common Shares Outstanding	-	66.07	66.07	66.07	66.07	66.07
Working Capital	-	0.07	-0.23	-0.37	-5.19	-5.7
Book Value Per Share	0.46	0.81	0.84	0.85	0.77	0.82
Tangible Book Value	52.92	53.74	55.2	56.39	50.9	54.27
Tangible Book Value Per Share	0.46	0.81	0.84	0.85	0.77	0.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.